Edgemont Capital Partners advises MedSN on merger with Indegene
MedSN, Inc., a leading medical education, sales training, and marketing services provider based in the United States, today announced that it has merged with the Indegene group of companies, the preeminent medical education, training, and marketing services provider in India and Asia. The combined companies will continue to operate in the United States as Medsn, Inc.
The newly merged firms bring to the fore proven development and delivery capabilities; a global talent pool exceeding 200, including more than 60 physicians, pharmacists, and allied health care professionals; and geographic coverage in the biggest and fastest-growing markets, with offices in Los Angeles, Jersey City, Chicago, Philadelphia, Bangalore, New Delhi, Mumbai, and Singapore. Medsn will now leverage the capabilities of its global workforce to deliver unprecedented quality in a timely and cost-effective manner to its pharmaceutical, biotechnology, and medical device customers in the United States. The merger will also significantly enhance Medsn’s ability to support the launches of its customers’ products worldwide.
“As our customers continue to expand their global presence in India and Asia,” says Dennis Bonilla, President and CEO of Medsn, “our newly forged partnership with Indegene will enable our firm to better address those customers’ strategic needs. While some companies have initiated off-shoring partnerships, this is the first and only example of two companies merging that have similar go-to-market strategies, are both market leaders in their geographies, and are both focused exclusively on one vertical, healthcare. Medsn and Indegene have combined their expertise for the past two years and have refined a delivery model that will significantly improve value to our clients. We are now in a position to drive global innovation, development, and delivery on a 24/7 basis to support the key customer needs of quality, cost, and speed to market. The combined teams of Indegene and Medsn, with their strong customer relationships in their respective geographies, will provide a solid foundation for growing a world-class company.”
“We are pioneering a unique model for providing medical education and marketing services that will leverage delivery capabilities and physician relationships from multiple geographies,” adds Dr. Rajesh Nair, President and CEO of Indegene. “With a footprint that currently spans the United States, Southeast Asia, and India, the Indegene/Medsn combination is poised to fundamentally change the dynamics of the industry.”
“We see this transaction as a key step toward establishing a world-class pharmaceutical and medical device services firm,” concludes Sriram Nadathur, Director of Nadathur Fareast, a leading private equity firm and investor in Indegene Group. “The Medsn-Indegene merger represents an important step in our plan to create a consortium of global companies ranging from drug discovery to pharmaceutical marketing that are dominant in their space. We believe that this approach will allow us to generate significant value.”
Edgemont Capital Partners served as exclusive adviser to MedSN.
Medsn is a premier medical education and marketing company that designs and implements customized interactive educational programs for the pharmaceutical, medical device, biotechnology, and health care industries. Medsn employs a multidisciplinary staff of physicians, marketing experts, industry executives, medical illustrators, and technology specialists — all with unique expertise in effectively merging interactive multimedia technologies with traditional educational methods — to develop high-impact programs that influence the behavior of physicians and patients as well as pharmaceutical and medical device sales representatives. The company is supported by key academic advisers at leading institutions as well as by experts in the fields of sales and marketing, communications, and learning.
For more information, visit www.medsn.com
About Indegene Group
Indegene is a global provider of knowledge-intensive services that span a full spectrum of integrated scientific promotions, medical education, and business analytical solutions for pharmaceutical, medical device, and health care organizations. Indegene has offices throughout India as well as subsidiaries in Singapore and the United States. The firm boasts a highly specialized team of physicians and medical professionals, content developers, analysts, brand managers, and medical communication experts. Indegene’s pioneering global delivery model for pharmaceutical services leverages its multi-geography, multimarket advantage to deliver medical content and communication services that provide significantly higher return on investment and shorter delivery time for clients.
For more information, visit www.indegene.com and www.indegeneusa.com
About Nadathur Group
Nadathur is a Bangalore, India–based private equity firm established by N. S. Raghavan, Founder and Former Joint Managing Director of Infosys (NASDAQ – INFY). Nadathur is focused on the life sciences, aerospace/engineering services, and IT domains. The firm supports a portfolio of more than 16 companies that are engaged in leading-edge technologies, knowledge-intensive domains, and IP creation. Through funding acquisitions and globalization initiatives, the firm is building market-dominant consortia of companies. Nadathur Fareast is the Singapore-based investment arm that facilitates expansion (both organic and inorganic) of portfolio companies.
For more information, visit www.nadathur.com
Dr. Rajesh Nair
David K. Blume
Edgemont Capital Partners
Phone: 212-867-8935 Fax: 212-214-0911